Matthias Salathe
Overview
Explore the profile of Matthias Salathe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
103
Citations
2676
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Apley K, Johnson S, Qian J, Munasinghe I, Klaus J, Patel S, et al.
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001420
: The pulmonary administration of antibiotics can be advantageous in treating pulmonary infections by promoting high intrapulmonary drug concentrations with reduced systemic exposure. However, limited benefits have been observed for...
2.
Mall M, Burgel P, Castellani C, Davies J, Salathe M, Taylor-Cousar J
Nat Rev Dis Primers
. 2024 Aug;
10(1):53.
PMID: 39117676
Cystic fibrosis is a rare genetic disease caused by mutations in CFTR, the gene encoding cystic fibrosis transmembrane conductance regulator (CFTR). The discovery of CFTR in 1989 has enabled the...
3.
Pisinger C, Vogelmeier C, Wilson A, Salathe M, Tarran R
Am J Respir Crit Care Med
. 2024 Jul;
210(7):867-868.
PMID: 39078200
No abstract available.
4.
Danahay H, McCarthy C, Schofield T, Fox R, Charlton H, Lilley S, et al.
J Cyst Fibros
. 2024 Jun;
24(1):72-78.
PMID: 38851923
Background: Inhibiting ENaC in the airways of people with cystic fibrosis (pwCF) is hypothesized to enhance mucociliary clearance (MCC) and provide clinical benefit. Historically, inhaled ENaC blockers have failed to...
5.
Tupayachi Ortiz M, Baumlin N, Yoshida M, Salathe M
Heliyon
. 2024 Mar;
10(5):e26955.
PMID: 38463894
Cystic fibrosis (CF) is caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) protein. Thousands of CFTR mutations have been identified, but only a fraction are known...
6.
Kim M, Chung S, Baumlin N, Qian J, Montgomery R, Sabater J, et al.
Sci Rep
. 2024 Jan;
14(1):1942.
PMID: 38253598
Despite concerns over their safety, e-cigarettes (e-cigs) remain a popular tobacco product. Although nicotine and flavors found in e-cig liquids (e-liquids) can cause harm in the airways, whether the delivery...
7.
Alhammad Y, Parthasarathy S, Ghimire R, Kerr C, OConnor J, Pfannenstiel J, et al.
Proc Natl Acad Sci U S A
. 2023 Aug;
120(35):e2302083120.
PMID: 37607224
Several coronavirus (CoV) encoded proteins are being evaluated as targets for antiviral therapies for COVID-19. Included in these drug targets is the conserved macrodomain, or Mac1, an ADP-ribosylhydrolase and ADP-ribose...
8.
OHalloran J, Ko E, Anstrom K, Kedar E, McCarthy M, Panettieri Jr R, et al.
JAMA
. 2023 Jul;
330(4):328-339.
PMID: 37428480
Importance: Immune dysregulation contributes to poorer outcomes in COVID-19. Objective: To investigate whether abatacept, cenicriviroc, or infliximab provides benefit when added to standard care for COVID-19 pneumonia. Design, Setting, And...
9.
Leni Z, Ess M, Keller A, Allan J, Hellen H, Saarnio K, et al.
Environ Sci Technol
. 2023 Jul;
57(28):10490.
PMID: 37404046
No abstract available.
10.
Campos M, Cickovski T, Fernandez M, Jaric M, Wanner A, Holt G, et al.
Access Microbiol
. 2023 Apr;
5(3).
PMID: 37091735
The lung microbiome impacts on lung function, making any smoking-induced changes in the lung microbiome potentially significant. The complex co-occurrence and co-avoidance patterns between the bacterial taxa in the lower...